Table 3

 Comparisons of mortality, NEC, and other perinatal outcomes between the donor breast milk and formula groups

Outcome and studiesSole diet comparisonSupplementary diet comparison
Donor breast milkFormulaRR (95% CI)p valueDonor breast milkFormulaRR (95% CI)p value
No.n (%)No.n (%)No.n (%)No.n (%)
NEC, necrotising ulcerative colitis; No., total; n, number of cases.
RR<1 favours donor breast milk.
Mortality up to 9 months
    Lucas et al17837 (8.4)769 (11.8)0.71 (0.28 to 1.82)p = 0.4817012 (7.1)17315 (8.7)0.81 (0.39 to 1.69)p = 0.58
Mortality up to 18 months
    Lucas et al17,19837 (8.4)769 (11.8)0.71 (0.28 to 1.82)p = 0.4817013 (7.6)17316 (9.2)0.83 (0.41 to 1.67)p = 0.59
Confirmed NEC
    Cooper et al23241 (4.2)153 (20.0)0.21 (0.02 to 1.82)p = 0.113
    Gross12411 (2.4)263 (11.5)0.21 (0.02 to 1.92)p = 0.126
    Lucas and Cole18861 (1.2)764 (5.3)0.22 (0.03 to 1.93)p = 0.131672 (1.2)1735 (2.9)0.41 (0.08 to 2.11)p = 0.27
Suspected NEC
    Lucas and Cole18863 (3.5)766 (7.9)0.44 (0.11 to 1.71)p = 0.221678 (4.8)1736 (3.5)1.38 (0.49 to 3.90)p = 0.54
Respiratory symptoms
    Cooper et al23243 (12.5)151 (6.7)1.87 (0.21 to 16.41)p = 0.56
Mild diarrhoea (culture negative)
    Schultz et al11100 (0)106 (60)0p = 0.011
Feeding intolerance, including NEC
    Gross12411 (2.4)266 (23.1)0.11 (0.01 to 0.83)p = 0.007
>2 weeks to tolerate full enteral feeds
    Lucas16839 (11)7625 (33)0.33 (0.16 to 0.66)p = 0.0007
>3 weeks to tolerate full enteral feeds
    Lucas16834 (5)7613 (17)0.28 (0.10 to 0.83)p = 0.012